K-Ras and its inhibitors towards personalized cancer treatment: Pharmacological and structural perspectives

V Asati, DK Mahapatra, SK Bharti - European journal of medicinal chemistry, 2017 - Elsevier
The discovery of genetic, genomic and clinical biomarkers have revolutionized the treatment
option in the form of personalized medicine which allows to accurately predict a person's …

[引用][C] K-Ras and its inhibitors towards personalized cancer treatment: Pharmacological and structural perspectives

V Asati, DK Mahapatra, SK Bharti - European Journal of Medicinal …, 2017 - cir.nii.ac.jp
K-Ras and its inhibitors towards personalized cancer treatment: Pharmacological and structural
perspectives | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …

K-Ras and its inhibitors towards personalized cancer treatment: Pharmacological and structural perspectives

V Asati, DK Mahapatra, SK Bharti - European Journal of Medicinal …, 2017 - infona.pl
The discovery of genetic, genomic and clinical biomarkers have revolutionized the treatment
option in the form of personalized medicine which allows to accurately predict a person's …

K-Ras and its inhibitors towards personalized cancer treatment: Pharmacological and structural perspectives

V Asati, DK Mahapatra… - European journal of …, 2017 - pubmed.ncbi.nlm.nih.gov
The discovery of genetic, genomic and clinical biomarkers have revolutionized the treatment
option in the form of personalized medicine which allows to accurately predict a person's …

K-Ras and its inhibitors towards personalized cancer treatment: Pharmacological and structural perspectives.

V Asati, DK Mahapatra, SK Bharti - European Journal of Medicinal …, 2016 - europepmc.org
The discovery of genetic, genomic and clinical biomarkers have revolutionized the treatment
option in the form of personalized medicine which allows to accurately predict a person's …